General Updates

06th July, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir/ Madam, Sub.: Pronouncement of final order by the Hon’ble National Company Law Tribunal, Ahmedabad Bench sanctioning the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders Ref.: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ==================================================================== This is to inform you that the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited ("Transferor Company") with Torrent Pharmaceuticals Limited ("Transferee Company") and their respective shareholders, under the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ("Scheme"), read with the rules framed thereunder, has been sanctioned by the Hon'ble National Company Law Tribunal ("Hon'ble NCLT") vide its order dated July 6, 2026 ("Order"). A copy of the Order is available on the website of the Hon'ble NCLT. The Scheme shall become effective upon filing of the certified copy of the Order with the Registrar of Companies. The Company will intimate the Stock Exchange of the effective date in due course, upon the Scheme becoming effective. Email – investorservices@torrentpharma.com Kindly take note of the above. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com